2010
DOI: 10.1016/j.biologicals.2009.10.006
|View full text |Cite
|
Sign up to set email alerts
|

Health economics of blood transfusion safety – focus on sub-Saharan Africa

Abstract: From a health economic viewpoint, HIV-antibody screening should always be implemented in sub-Saharan Africa. The addition of HIV-p24 antigen screening, in combination with HCV antibody/antigen screening and multiplex (HBV, HCV and HIV) NAT in pools of 24 may be feasible options for Ghana. Suggestions for future health economic evaluations of blood transfusion safety interventions in sub-Saharan Africa are: mis-transfusion, laboratory quality and donor management.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
26
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
6
1
1

Relationship

0
8

Authors

Journals

citations
Cited by 25 publications
(26 citation statements)
references
References 56 publications
(52 reference statements)
0
26
0
Order By: Relevance
“…WHO reported that 38% of voluntarily donated blood comes from those young people aged less than 25. There is a need to motivate young generations to meet 100% voluntary not-paid blood donation [16]. …”
Section: Introductionmentioning
confidence: 99%
“…WHO reported that 38% of voluntarily donated blood comes from those young people aged less than 25. There is a need to motivate young generations to meet 100% voluntary not-paid blood donation [16]. …”
Section: Introductionmentioning
confidence: 99%
“…To meet demand, countries often rely on family or replacement donors who donate blood for a family member or friend; however, such donations carry a higher risk for TTIs ( 6 ). Since 2004, PEPFAR support has helped establish national blood policies, improved blood donor screening, increased recruitment and reliance on VNRDs for national supplies, and strengthened laboratory infrastructure, accreditation, information systems, and continuous quality improvement programs ( 4 ).…”
mentioning
confidence: 99%
“…Actually, the transfusion financing system either depends on governments' budgets or on cost recovery by public or private health insurance companies (Table ) similarly to what was stated also by the WHO . In both situations, a sustainable organised national transfusion system would require governments' engagement and specific financing at least for the capacity of building national regulatory authorities …”
Section: Discussionmentioning
confidence: 59%